Browse by Medical Category
Lab Phone: 617-643-0680
Neurology Access Center 1-855-644-6387
MassGeneral Institute for Neurodegenerative Disease (MIND)
The Albers’s Laboratory uses the olfactory system of mice and humans to elucidate early pathologic events of neurodegeneration in order to find: (1) a detailed mechanistic understanding of early pathogenic processes that are modifiable or reversible, and (2) a means to detect early stages of these diseases in humans before the onset of symptoms and distinguish early pathologic events from changes produced by aging.
In the laboratory, we combine molecular biological, anatomical, physiological and behavioral techniques to test hypotheses regarding the mechanism of actions of genes associated with neurodegenerative disease. We have generated transgenic mouse lines that express genes associated with Alzheimer's disease and other neurodegenerative diseases in defined olfactory neuron populations with temporal control using a tetracycline-regulated transcription factor. We will be extending this experimental approach to genes associated with other neurodegenerative diseases, such as frontal temporal dementia and Parkinson’s disease.
In human studies, an odor-naming deficit is one of the strongest biomarkers to predict the development of AD in a person with mild memory complaints. We have identified ten odors that independently predict the conversion of people with mild cognitive impairment to patients with AD. We are using these ten odors in an odor-induced fMRI paradigm to decipher areas of the olfactory neural circuit that are selectively affected early in the disease course. Results from these studies will inform the development of the next generation of olfactory screening tests and identify sites in the olfactory neural circuit for further study in the mouse system.
Mark W. Albers, MD, PhD
Read about and apply for residency, fellowship and observership programs at http://www.massgeneral.org/neurology/education.
All applicants should register with the Mass General Careers Web site at http://www.massgeneral.org/careers/viewall.aspx. Request a list of current open positions at firstname.lastname@example.org.
NCBI PubMed Publications
Albers Laboratory Mark W Albers
Building 114, Charlestown Navy Yard
Phone & Fax
Lab Phone: 617-643-3-0680 Lab Fax: 617-764-1480
Mark W. Albers, MD, PhD Mailcode: CNY B114-2-2003 MassGeneral Institute for Neurodegenerative Disease (MIND) 114 16th Street, Room 2003 Charlestown, MA 02129
Patient Appointments & Clinical OfficeMemory Disorders Unit, Department of Neurology
Back to Top